Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency
NCT06095141
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Adenocarcinoma
Homologous Recombination Deficiency
Interventions
DRUG:
Cisplatin
Sponsor
Fudan University